CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-04-24
DOI
10.3389/fimmu.2019.00760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
- (2018) Tina Cascone et al. Cell Metabolism
- Activation of Adenylyl Cyclase Causes Stimulation of Adenosine Receptors
- (2018) Thomas Pleli et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- CD38-targeting antibodies in multiple myeloma: mechanisms of action and clinical experience
- (2018) Kristine A. Frerichs et al. Expert Review of Clinical Immunology
- Interplay between adenylate metabolizing enzymes and AMP-activated protein kinase
- (2018) Marcella Camici et al. FEBS Journal
- The link between bone microenvironment and immune cells in multiple myeloma: Emerging role of CD38
- (2018) Marina Bolzoni et al. IMMUNOLOGY LETTERS
- Canonical and non-canonical adenosinergic pathways
- (2018) E. Ferretti et al. IMMUNOLOGY LETTERS
- Mechanisms of Intrinsic Tumor Resistance to Immunotherapy
- (2018) John Rieth et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer
- (2018) Nicholas Borcherding et al. JOURNAL OF MOLECULAR BIOLOGY
- Inosine alleviates depression-like behavior and increases the activity of the ERK-CREB signaling in adolescent male rats
- (2018) Shuai Yuan et al. NEUROREPORT
- Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
- (2018) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade
- (2018) Limo Chen et al. Cancer Discovery
- Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
- (2018) Alberto L. Horenstein et al. Frontiers in Pharmacology
- Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD+
- (2018) F. Morandi et al. OncoImmunology
- Abstract 2122: Induction of structural and functional effects of myeloma cells after daratumumab treatment
- (2018) Barbara Castella et al. CANCER RESEARCH
- Trogocytosis represents a novel mechanism of action of daratumumab in multiple myeloma
- (2018) Jakub Krejcik et al. Oncotarget
- CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance
- (2018) Niels W.C.J. van de Donk et al. Frontiers in Immunology
- Functional insights into nucleotide-metabolizing ectoenzymes expressed by bone marrow-resident cells in patients with multiple myeloma
- (2018) A.L. Horenstein et al. IMMUNOLOGY LETTERS
- Targeting adenosine in cancer immunotherapy: a review of recent progress
- (2017) Theresa L Whiteside Expert Review of Anticancer Therapy
- Introduction to checkpoint inhibitors and cancer immunotherapy
- (2017) Arlene H. Sharpe IMMUNOLOGICAL REVIEWS
- Targeting A2 adenosine receptors in cancer
- (2017) David Allard et al. IMMUNOLOGY AND CELL BIOLOGY
- Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials
- (2017) P Arana et al. LEUKEMIA
- Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells
- (2017) Giulia Mesiano et al. MOLECULAR MEDICINE
- Expression of CD38 in myeloma bone niche: A rational basis for the use of anti-CD38 immunotherapy to inhibit osteoclast formation
- (2017) Federica Costa et al. Oncotarget
- What Else Can CD39 Tell Us?
- (2017) Hai Zhao et al. Frontiers in Immunology
- Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche
- (2017) Antonella Chillemi et al. Frontiers in Immunology
- Osteoclasts promote immune suppressive microenvironment in multiple myeloma: therapeutic implication
- (2016) G. An et al. BLOOD
- LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
- (2016) Almut Brand et al. Cell Metabolism
- Immune Therapies in Multiple Myeloma
- (2016) Shaji K. Kumar et al. CLINICAL CANCER RESEARCH
- Cell autonomous and microenvironmental regulation of tumor progression in precursor states of multiple myeloma
- (2016) Salomon Manier et al. CURRENT OPINION IN HEMATOLOGY
- Immunosuppressive activities of adenosine in cancer
- (2016) Bertrand Allard et al. CURRENT OPINION IN PHARMACOLOGY
- Increase of CIK cell efficacy by upregulating cell surface MICA and inhibition of NKG2D ligand shedding in multiple myeloma
- (2016) Chidimma A. Nwangwu et al. HEMATOLOGICAL ONCOLOGY
- Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
- (2016) Niels W. C. J. van de Donk et al. IMMUNOLOGICAL REVIEWS
- Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates With Progression of Human Myeloma
- (2016) Alberto L Horenstein et al. MOLECULAR MEDICINE
- Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma
- (2016) Meletios A. Dimopoulos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma
- (2016) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment
- (2016) Akio Ohta Frontiers in Immunology
- Pathogenesis beyond the cancer clone(s) in multiple myeloma
- (2015) G. Bianchi et al. BLOOD
- CD56brightCD16−NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+T Cell Proliferation
- (2015) Fabio Morandi et al. JOURNAL OF IMMUNOLOGY
- Unconventional, adenosine-producing suppressor T cells induced by dendritic cells exposed to BPZE1 pertussis vaccine
- (2015) G. Fedele et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies
- (2015) T Dosani et al. Blood Cancer Journal
- A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation
- (2015) Fabio Morandi et al. Oncotarget
- NAD+-Metabolizing Ectoenzymes in Remodeling Tumor–Host Interactions: The Human Myeloma Model
- (2015) Alberto Horenstein et al. Cells
- Failure of anti tumor-derived endothelial cell immunotherapy depends on augmentation of tumor hypoxia
- (2015) Annalisa Pezzolo et al. Oncotarget
- Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche
- (2014) Valeria Quarona et al. Annals of the New York Academy of Sciences
- Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
- (2014) D. Mittal et al. CANCER RESEARCH
- The ADP-ribosyl cyclases - the current evolutionary state of the ARCs
- (2014) Enza et al. Frontiers in Bioscience-Landmark
- Tumor cells hijack macrophages via lactic acid
- (2014) Vincenzo Bronte IMMUNOLOGY AND CELL BIOLOGY
- Targeting Cancer-Derived Adenosine:New Therapeutic Approaches
- (2014) A. Young et al. Cancer Discovery
- Hostile, Hypoxia-A2-Adenosinergic Tumor Biology as the Next Barrier to Overcome for Tumor Immunologists
- (2014) M. V. Sitkovsky et al. Cancer Immunology Research
- Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
- (2013) G. T. Gorgun et al. BLOOD
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
- (2013) Gregg L. Semenza JOURNAL OF CLINICAL INVESTIGATION
- Effect of Ionic Strength and pH on the Physical and Chemical Stability of a Monoclonal Antibody Antigen-Binding Fragment
- (2013) Tingting Wang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013
- (2013) Joseph R. Mikhael et al. MAYO CLINIC PROCEEDINGS
- CD38 Ligation in Peripheral Blood Mononuclear Cells of Myeloma Patients Induces Release of Protumorigenic IL-6 and Impaired Secretion of IFNγCytokines and Proliferation
- (2013) Giorgio Fedele et al. MEDIATORS OF INFLAMMATION
- Metabolomics Identifies Pyrimidine Starvation as the Mechanism of 5-Aminoimidazole-4-Carboxamide-1- -Riboside-Induced Apoptosis in Multiple Myeloma Cells
- (2013) C. Bardeleben et al. MOLECULAR CANCER THERAPEUTICS
- Unknown
- (2013) Antonella Chillemi et al. MOLECULAR MEDICINE
- Impact of Interleukin-6 in Hematological Malignancies
- (2013) Renate Burger TRANSFUSION MEDICINE AND HEMOTHERAPY
- A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes
- (2013) Alberto L Horenstein et al. OncoImmunology
- Molecular pathogenesis of multiple myeloma and its premalignant precursor
- (2012) W. Michael Kuehl et al. JOURNAL OF CLINICAL INVESTIGATION
- ATP and ADP hydrolysis in cell membranes from rat myometrium
- (2012) Maja Milošević et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The development and immunosuppressive functions of CD4+ CD25+ FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway
- (2012) Akio Ohta et al. Frontiers in Immunology
- CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
- (2011) S. Serra et al. BLOOD
- Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma
- (2011) Sally A. Hunsucker et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Multidrug Resistance Protein 4 (MRP4/ABCC4) Regulates cAMP Cellular Levels and Controls Human Leukemia Cell Proliferation and Differentiation
- (2011) Sabrina Copsel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Elucidation of Acid-induced Unfolding and Aggregation of Human Immunoglobulin IgG1 and IgG2 Fc
- (2011) Ramil F. Latypov et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors--An Update
- (2011) B. B. Fredholm et al. PHARMACOLOGICAL REVIEWS
- Influence of pH on Heat-Induced Aggregation and Degradation of Therapeutic Monoclonal Antibodies
- (2010) Tomoyoshi Ishikawa et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Extracellular adenosine triphosphate and adenosine in cancer
- (2010) J Stagg et al. ONCOGENE
- Unknown
- (2009) Alberto Horenstein et al. MOLECULAR MEDICINE
- Staging Systems and Prognostic Factors as a Guide to Therapeutic Decisions in Multiple Myeloma
- (2009) Marie-Christine Kyrtsonis et al. SEMINARS IN HEMATOLOGY
- Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells
- (2008) M Sitkovsky et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cancer Cell Metabolism: Warburg and Beyond
- (2008) Peggy P. Hsu et al. CELL
- Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
- (2008) M. V. Sitkovsky et al. CLINICAL CANCER RESEARCH
- Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters
- (2008) Cinzia Volonté et al. FEBS Journal
- Cyclic AMP in Rat Ileum: Evidence for the Presence of an Extracellular Cyclic AMP-Adenosine Pathway
- (2008) Maria Cecilia Giron et al. GASTROENTEROLOGY
- Pathogenesis of myeloma bone disease
- (2008) G D Roodman LEUKEMIA
- Evolution and Function of the ADP Ribosyl Cyclase/CD38 Gene Family in Physiology and Pathology
- (2008) Fabio Malavasi et al. PHYSIOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started